SK bioscience Co.,Ltd. Statistics

Total Valuation

SK bioscience Co.,Ltd. has a market cap or net worth of KRW 3.51 trillion. The enterprise value is 2.38 trillion.

Market Cap	3.51T
Enterprise Value	2.38T

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	n/a

Share Statistics

SK bioscience Co.,Ltd. has 78.35 million shares outstanding. The number of shares has increased by 0.17% in one year.

Current Share Class	n/a
Shares Outstanding	78.35M
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	4.30%
Float	25.81M

Valuation Ratios

The trailing PE ratio is 125.80.

PE Ratio	125.80
Forward PE	n/a
PS Ratio	9.27
PB Ratio	1.98
P/TBV Ratio	n/a
P/FCF Ratio	139.74
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 58.54, with an EV/FCF ratio of 94.61.

EV / Earnings	86.72
EV / Sales	6.40
EV / EBITDA	58.54
EV / EBIT	n/a
EV / FCF	94.61

Financial Position

The company has a current ratio of 10.12, with a Debt / Equity ratio of 0.06.

Current Ratio	10.12
Quick Ratio	9.15
Debt / Equity	0.06
Debt / EBITDA	2.45
Debt / FCF	3.96
Interest Coverage	4.64

Financial Efficiency

Return on equity (ROE) is 1.59% and return on invested capital (ROIC) is 0.16%.

Return on Equity (ROE)	1.59%
Return on Assets (ROA)	0.14%
Return on Capital (ROIC)	0.16%
Revenue Per Employee	377.52M
Profits Per Employee	27.88M
Employee Count	984
Asset Turnover	0.19
Inventory Turnover	1.18

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.38% in the last 52 weeks. The beta is 1.19, so SK bioscience Co.,Ltd.'s price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	-33.38%
50-Day Moving Average	53,371.00
200-Day Moving Average	56,773.50
Relative Strength Index (RSI)	25.03
Average Volume (20 Days)	93,640

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SK bioscience Co.,Ltd. had revenue of KRW 371.48 billion and earned 27.43 billion in profits. Earnings per share was 356.51.

Revenue	371.48B
Gross Profit	158.03B
Operating Income	4.47B
Pretax Income	25.52B
Net Income	27.43B
EBITDA	40.64B
EBIT	4.47B
Earnings Per Share (EPS)	356.51

Full Income Statement

Balance Sheet

The company has 1.22 trillion in cash and 99.48 billion in debt, giving a net cash position of 1.12 trillion or 14,245.66 per share.

Cash & Cash Equivalents	1.22T
Total Debt	99.48B
Net Cash	1.12T
Net Cash Per Share	14,245.66
Equity (Book Value)	1.74T
Book Value Per Share	22,619.30
Working Capital	1.24T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 135.18 billion and capital expenditures -110.03 billion, giving a free cash flow of 25.15 billion.

Operating Cash Flow	135.18B
Capital Expenditures	-110.03B
Free Cash Flow	25.15B
FCF Per Share	320.95

Full Cash Flow Statement

Margins

Gross margin is 42.54%, with operating and profit margins of 1.20% and 7.39%.

Gross Margin	42.54%
Operating Margin	1.20%
Pretax Margin	6.87%
Profit Margin	7.39%
EBITDA Margin	10.94%
EBIT Margin	1.20%
FCF Margin	6.77%

Dividends & Yields

SK bioscience Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.17%
Shareholder Yield	-0.17%
Earnings Yield	0.79%
FCF Yield	0.72%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SK bioscience Co.,Ltd. has an Altman Z-Score of 14.53.

Altman Z-Score	14.53
Piotroski F-Score	n/a